SB478

Regulates prescription drug costs by banning spread pricing, requiring pass-through pricing, directing manufacturer rebates toward lowering premiums or point-of-sale costs, banning retroactive fees on clean claims, requiring timely access to pricing lists, and permitting audits.

relative to strengthening prescription drug affordability and pharmacy benefits manager accountability.